These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37996237)

  • 61. Critical Contextual Elements in Facilitating and Achieving Success with a Person-Centred Care Intervention to Support Antipsychotic Deprescribing for Older People in Long-Term Care.
    Chenoweth L; Jessop T; Harrison F; Cations M; Cook J; Brodaty H
    Biomed Res Int; 2018; 2018():7148515. PubMed ID: 30069476
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Negotiating "Unmeasurable Harm and Benefit": Perspectives of General Practitioners and Consultant Pharmacists on Deprescribing in the Primary Care Setting.
    Anderson K; Foster M; Freeman C; Luetsch K; Scott I
    Qual Health Res; 2017 Nov; 27(13):1936-1947. PubMed ID: 29088989
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups.
    Evrard P; Damiaens A; Patey AM; Grimshaw JM; Spinewine A
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100258. PubMed ID: 37124470
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Using the behavior change wheel to link published deprescribing strategies to identified local primary healthcare needs.
    Bai I; Isenor JE; Reeve E; Whelan AM; Martin-Misener R; Burgess S; Kennie-Kaulbach N
    Res Social Adm Pharm; 2022 Aug; 18(8):3350-3357. PubMed ID: 34895842
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antihypertensive Deprescribing in Older Adult Veterans at End of Life Admitted to Veteran Affairs Nursing Homes.
    Vu M; Sileanu FE; Aspinall SL; Niznik JD; Springer SP; Mor MK; Zhao X; Ersek M; Hanlon JT; Gellad WF; Schleiden LJ; Thorpe JM; Thorpe CT
    J Am Med Dir Assoc; 2021 Jan; 22(1):132-140.e5. PubMed ID: 32723537
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacist-independent prescriber deprescribing in UK care homes: Contextual factors associated with increased activity.
    Alharthi M; Scott S; Alldred DP; Holland R; Hughes C; Birt L; Blacklock J; Bond C; Clark A; Wright D
    Br J Clin Pharmacol; 2023 Apr; 89(4):1509-1513. PubMed ID: 36516106
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Facilitators and Barriers Influencing Antipsychotic Medication Prescribing and Deprescribing Practices in Critically Ill Adult Patients: a Qualitative Study.
    Jaworska N; Krewulak KD; Schalm E; Niven DJ; Ismail Z; Burry LD; Leigh JP; Fiest KM
    J Gen Intern Med; 2023 Aug; 38(10):2262-2271. PubMed ID: 37072535
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Barriers and enablers of older adults initiating a deprescribing conversation.
    Ailabouni NJ; Rebecca Weir K; Reeve E; Turner JT; Wilson Norton J; Gray SL
    Patient Educ Couns; 2022 Mar; 105(3):615-624. PubMed ID: 34183219
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Association of Deprescribing With Reduction in Mortality and Hospitalization: A Pragmatic Stepped-Wedge Cluster-Randomized Controlled Trial.
    Kua CH; Yeo CYY; Tan PC; Char CWT; Tan CWY; Mak V; Leong IY; Lee SWH
    J Am Med Dir Assoc; 2021 Jan; 22(1):82-89.e3. PubMed ID: 32423694
    [TBL] [Abstract][Full Text] [Related]  

  • 70. What Makes Deprescription of Psychotropic Drugs in Nursing Home Residents with Dementia so Challenging? A Qualitative Systematic Review of Barriers and Facilitators.
    Moth AE; Hølmkjær P; Holm A; Rozing MP; Overbeck G
    Drugs Aging; 2021 Aug; 38(8):671-685. PubMed ID: 34231182
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A group intervention to improve quality of life for people with advanced dementia living in care homes: the Namaste feasibility cluster RCT.
    Froggatt K; Best A; Bunn F; Burnside G; Coast J; Dunleavy L; Goodman C; Hardwick B; Jackson C; Kinley J; Davidson Lund A; Lynch J; Mitchell P; Myring G; Patel S; Algorta GP; Preston N; Scott D; Silvera K; Walshe C
    Health Technol Assess; 2020 Jan; 24(6):1-140. PubMed ID: 31971506
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk for Health Events After Deprescribing Acetylcholinesterase Inhibitors in Nursing Home Residents With Severe Dementia.
    Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Hanson LC; Nace D; Thorpe JM; Thorpe CT
    J Am Geriatr Soc; 2020 Apr; 68(4):699-707. PubMed ID: 31769507
    [TBL] [Abstract][Full Text] [Related]  

  • 73. What happens when pharmacist independent prescribers lead on medicine management in older people's care homes: a qualitative study.
    Birt L; Dalgarno L; Poland F; Wright D; Bond C
    BMJ Open; 2023 Oct; 13(10):e068678. PubMed ID: 37907299
    [TBL] [Abstract][Full Text] [Related]  

  • 74. How do inner and outer settings affect implementation of a community-based innovation for older adults with a serious illness: a qualitative study.
    Warner G; Kervin E; Pesut B; Urquhart R; Duggleby W; Hill T
    BMC Health Serv Res; 2021 Jan; 21(1):42. PubMed ID: 33413394
    [TBL] [Abstract][Full Text] [Related]  

  • 75. GPs' mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice.
    Kuberska K; Scheibl F; Sinnott C; Sheppard JP; Lown M; Williams M; Payne RA; Mant J; McManus RJ; Burt J
    Br J Gen Pract; 2021 Jul; 71(708):e498-e507. PubMed ID: 34001537
    [TBL] [Abstract][Full Text] [Related]  

  • 76. How to Deprescribe Potentially Inappropriate Medications During the Hospital-to-Home Transition: Stakeholder Perspectives on Essential Tasks.
    Wang J; Shen JY; Yu F; Nathan K; Caprio TV; Conwell Y; Moskow MS; Brasch JD; Simmons SF; Mixon AS; Norton SA
    Clin Ther; 2023 Oct; 45(10):947-956. PubMed ID: 37640614
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors.
    Onder G; Vetrano DL; Villani ER; Carfì A; Lo Monaco MR; Cipriani MC; Manes Gravina E; Denkinger M; Pagano F; van der Roest HG; Bernabei R
    J Am Med Dir Assoc; 2019 Sep; 20(9):1116-1120. PubMed ID: 30853425
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Healthcare stakeholders' perceptions and experiences of factors affecting the implementation of critical care telemedicine (CCT): qualitative evidence synthesis.
    Xyrichis A; Iliopoulou K; Mackintosh NJ; Bench S; Terblanche M; Philippou J; Sandall J
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012876. PubMed ID: 33599282
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The potential for deprescribing in care home residents with Type 2 diabetes.
    Andreassen LM; Kjome RL; Sølvik UØ; Houghton J; Desborough JA
    Int J Clin Pharm; 2016 Aug; 38(4):977-84. PubMed ID: 27241345
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.